loading
Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CRBU Giù? Forum Previsione
Precedente Chiudi:
$1.81
Aprire:
$1.78
Volume 24 ore:
1.97M
Relative Volume:
1.49
Capitalizzazione di mercato:
$162.99M
Reddito:
$34.48M
Utile/perdita netta:
$-102.07M
Rapporto P/E:
-0.989
EPS:
-1.82
Flusso di cassa netto:
$-104.90M
1 W Prestazione:
-5.76%
1M Prestazione:
-8.16%
6M Prestazione:
+4.65%
1 anno Prestazione:
-69.39%
Intervallo 1D:
Value
$1.755
$1.86
Intervallo di 1 settimana:
Value
$1.72
$1.97
Portata 52W:
Value
$1.50
$8.33

Caribou Biosciences Inc Stock (CRBU) Company Profile

Name
Nome
Caribou Biosciences Inc
Name
Settore
Healthcare (1176)
Name
Industria
Biotechnology (673)
Name
Telefono
510-982-6030
Name
Indirizzo
2929 7TH STREET, SUITE 105, BERKELEY
Name
Dipendente
137
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CRBU's Discussions on Twitter

Confronta CRBU con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CRBU
Caribou Biosciences Inc
 1.80 162.99M 34.48M -102.07M -104.90M -1.46
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
 623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
 113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-03 Downgrade Evercore ISI Outperform → In-line
2023-11-08 Iniziato Cantor Fitzgerald Neutral
2023-10-31 Iniziato Evercore ISI Outperform
2023-07-11 Iniziato Truist Buy
2022-02-18 Iniziato RBC Capital Mkts Outperform
2021-12-01 Iniziato Oppenheimer Outperform
2021-11-30 Iniziato H.C. Wainwright Buy
2021-11-15 Aggiornamento Citigroup Neutral → Buy
2021-08-17 Iniziato BofA Securities Buy
2021-08-17 Iniziato Citigroup Neutral
2021-08-17 Iniziato SVB Leerink Outperform
Mostra tutto

Caribou Biosciences Inc Borsa (CRBU) Ultime notizie

pulisher
Dec 17, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Position Boosted by Charles Schwab Investment Management Inc. - Defense World

Dec 17, 2024
pulisher
Dec 16, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Short Interest Up 16.2% in November - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Caribou Biosciences (CRBU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Zacks Investment Research

Dec 16, 2024
pulisher
Dec 13, 2024

Caribou Biosciences' SWOT analysis: gene editing firm's stock faces pivotal year - Investing.com Australia

Dec 13, 2024
pulisher
Nov 28, 2024

Caribou Biosciences price target lowered to $6 from $30 at Citi - MSN

Nov 28, 2024
pulisher
Nov 21, 2024

Caribou Biosciences Reports Q3 2024 Financial Results - TipRanks

Nov 21, 2024
pulisher
Nov 20, 2024

Caribou Biosciences to Participate in Upcoming Investor Conferences - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Caribou Biosciences CEO to Present at Major Healthcare Conferences on CRISPR Advances | CRBU Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 18, 2024

The Rosen Law Firm, P.A. Announces Proposed Class Action - GlobeNewswire

Nov 18, 2024
pulisher
Nov 18, 2024

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Caribou Biosciences, Inc. – CRBU - GlobeNewswire Inc.

Nov 18, 2024
pulisher
Nov 15, 2024

Steven Cohen's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Caribou Biosciences (NASDAQ:CRBU) Receives Buy Rating from HC Wainwright - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

PFM Health Sciences, LP Increases Stake in Caribou Biosciences I - GuruFocus.com

Nov 15, 2024
pulisher
Nov 13, 2024

Caribou Biosciences' SWOT analysis: biotech stock's potential amid clinical trials - Investing.com Australia

Nov 13, 2024
pulisher
Nov 12, 2024

Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 12, 2024
pulisher
Nov 11, 2024

Brokers Set Expectations for CRBU FY2024 Earnings - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Leerink Partnrs Issues Optimistic Forecast for CRBU Earnings - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

What is Leerink Partnrs' Forecast for CRBU FY2024 Earnings? - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

CRBU FY2024 EPS Increased by Brookline Capital Management - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews

Nov 11, 2024
pulisher
Nov 10, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Nov 10, 2024
pulisher
Nov 09, 2024

Caribou Biosciences (NASDAQ:CRBU) Announces Quarterly Earnings Results - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Caribou Biosciences (NASDAQ:CRBU) vs. Sutro Biopharma (NASDAQ:STRO) Financial Analysis - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

Caribou Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 08, 2024
pulisher
Nov 07, 2024

Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 07, 2024
pulisher
Nov 06, 2024

Caribou Biosciences earnings beat by $0.07, revenue fell short of estimates - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

Caribou Biosciences reports Q3 EPS (38c), consensus (45c) - TipRanks

Nov 06, 2024
pulisher
Nov 06, 2024

CRISPR Technology Market Report 2024, with Profiles of Major Players Agilent Technologies, Beam Therapeutics, Caribou Biosciences, Crispr Therapeutics, Danaher, Genscript, Lonza and MoreResearchAndMarkets.com | FinancialContent Business Page - Financial Content

Nov 06, 2024
pulisher
Nov 05, 2024

Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Shares Bounce 25% But Its Business Still Trails The Industry - Simply Wall St

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 03, 2024

Critical Analysis: Caribou Biosciences (NASDAQ:CRBU) & Titan Pharmaceuticals (NASDAQ:TTNP) - Defense World

Nov 03, 2024
pulisher
Oct 31, 2024

Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock? - Insider Monkey

Oct 31, 2024
pulisher
Oct 30, 2024

10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey

Oct 30, 2024
pulisher
Oct 24, 2024

Precision BioSciences to Report Q3 Earnings: What's in the Cards? - Yahoo Finance

Oct 24, 2024
pulisher
Oct 22, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Exchange Traded Concepts LLC - Defense World

Oct 22, 2024
pulisher
Oct 17, 2024

STATE STREET CORP's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Oct 17, 2024
pulisher
Oct 17, 2024

Following a 49% decline over last year, recent gains may please Caribou Biosciences, Inc. (NASDAQ:CRBU) institutional owners - Simply Wall St

Oct 17, 2024
pulisher
Oct 16, 2024

Its Stock Has Paid Off Big Time For Caribou Biosciences Inc - SETE News

Oct 16, 2024
pulisher
Oct 15, 2024

How to interpret Caribou Biosciences Inc (CRBU)’s stock chart patterns - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 5.56 Increase, Closing at 1.90 - The Dwinnex

Oct 14, 2024
pulisher
Oct 10, 2024

Dimensional Fund Advisors LP Has $4.30 Million Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

A better buy-in window may exist right now for Caribou Biosciences Inc (CRBU) - SETE News

Oct 09, 2024
pulisher
Oct 08, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Purchased by Green Alpha Advisors LLC - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Caribou Biosciences Inc (CRBU) presents a great opportunity, but the stock is slightly undervalued - US Post News

Oct 08, 2024
pulisher
Oct 07, 2024

Analyzing Ratios: Caribou Biosciences Inc (CRBU)’s Financial Story Unveiled - The Dwinnex

Oct 07, 2024
pulisher
Oct 06, 2024

Susquehanna Fundamental Investments LLC Sells 91,637 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Oct 06, 2024

Caribou Biosciences Inc Azioni (CRBU) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Simile a CRBU

biotechnology SMMT
$17.87
price down icon 2.88%
biotechnology INCY
$68.84
price up icon 2.65%
biotechnology MRNA
$39.39
price down icon 0.43%
biotechnology UTHR
$359.58
price down icon 0.16%
biotechnology BGNE
$176.50
price up icon 1.02%
biotechnology BNTX
$113.08
price up icon 1.56%
Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters
Capitalizzazione:     |  Volume (24 ore):